News for Paradigm Biopharmaceuticals Limited (PBIGF)

Published at

Aug 15, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Global Non-Steroidal Anti-Inflammatory Drugs Market is Expected to Showcase a Significant Growth at a CAGR of ~6% by 2030 | DelveInsight

The NSAIDs market is experiencing significant growth due to the rising incidence of chronic pain and inflammatory conditions such as arthritis and...

STAR.NS STAR.BO PBIGF HKMPY HKMPF HIK.L GXE.DE GLPGF GLPG.AS GLPG GLAXF GILDD.BA VTRSV VTRS.MX VTRS VIA.DE TEVJF SUNPHARMA-BL.NS SNCPF RKT.L RBN.MX RBGPF RBGLY RB.L PRGON.MX PRGO.TA PRGO PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE P1RG34.SA NVSEF MRKD.BA MRK.SN MRK.PA MRK.MX MRK LLY.MX LLY.DE LLY.BA LLY LILY34.SA JNJ HRTX ENDP DJNJ3.BA DJNJ2.BA CYYNF AZNCF ASRT AHKSY AHKSF 6MK.DE 3RB.DE 244460.KQ 0Y5F.L 0Y5E.L 0Q1G.L 0J4V.L ATBPF

Read more →
Published at

Apr 4, 2023 3:55 AM

by stockhead.com.au

positive

positive

ASX Health Stocks: Paradigm shows good Phase 2 results, Race Oncology jumps 8pc after third party report on Zantrene

Paradigm Biopharma said that injectable pentosan polysulfate sodium (iPPS) may slow disease progression in knee osteoarthritis (OA).

VCCTF RAONF RAC.AX PBIGF PAR.AX EMD.AX ASXFY ASXFF APZ.AX

Read more →
Published at

Nov 24, 2021 6:40 AM

by marketscreener.com

neutral

neutral

Paradigm Biopharmaceuticals : Application for quotation of securities - PAR

Application for quotation of +securities Announcement Summary For personal use only ... | November 24, 2021

PBIGF PAR.AX

Read more →
Published at

Nov 23, 2021 9:45 AM

by globenewswire.com

mixed

mixed

Proactive news headlines including European Lithium, Strickland Metals, Euro Manganese and Marmota Ltd

Sydney, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered...

PBIGF PAR.AX OTCM MXR.AX LRS.AX GBR.AX EUR.AX EUMNF EROMF EMN.V EMN.AX DCYHY DCYHF CV1.AX BSX.AX BRU.AX BRNGF BLSTF AWCMY AWCMF AWC.AX ASXFY ASXFF APC.AX AA STK.AX QML.AX MEU.AX HFR.AX FYIRF FYI.AX ARR.AX

Read more →